The Union Health Ministry has approved the fixed-dose combination (FDC) of Tamsulosin HCI and Deflazacort for asthma therapy through a gazetted notification.
The notification said that the fixed-dose combination of Tamsulosin HCI 0.4 mg and Deflazacort 30mg in hard gelatine capsule will be withdrawn from the list of medicines that are banned for manufacture and sale.
Antibiotic use has surged globally, leading to a rise in antibiotic resistance, especially concerning in…
Choking is a leading cause of injury and death in young children, particularly those under…
Hard Water (Khara Pani) Leading To Hair Fall Hard water is rich in minerals and…
Discover how the rise in high blood pressure during pregnancy is impacting maternal and fetal…
"Discover the transformative power of six delicious homemade drinks that can help you naturally melt…
"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…